Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,791 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors associated with viral RNA shedding and evaluation of potential viral infectivity at returning to school in influenza outpatients after treatment with baloxavir marboxil and neuraminidase inhibitors during 2013/2014-2019/2020 seasons in Japan: an observational study.
Li J, Wagatsuma K, Sun Y, Sato I, Kawashima T, Saito T, Shimada Y, Ono Y, Kakuya F, Nagata N, Minato M, Kodo N, Suzuki E, Kitano A, Tanaka T, Aoki S, Chon I, Phyu WW, Watanabe H, Saito R. Li J, et al. Among authors: suzuki e. BMC Infect Dis. 2023 Mar 29;23(1):188. doi: 10.1186/s12879-023-08140-z. BMC Infect Dis. 2023. PMID: 36991360 Free PMC article.
Duration of fever and symptoms in influenza-infected children treated with baloxavir marboxil during the 2019-2020 season in Japan and detection of influenza virus with the PA E23K substitution.
Wagatsuma K, Saito R, Chon I, Phyu WW, Fujio K, Kawashima T, Sato I, Saito T, Minato M, Kodo N, Suzuki E, Ono Y, Masaki H, Shirahige Y, Kitano A, Hamabata H, Yuyang S, Jiaming L, Watanabe H. Wagatsuma K, et al. Among authors: suzuki e. Antiviral Res. 2022 May;201:105310. doi: 10.1016/j.antiviral.2022.105310. Epub 2022 Mar 28. Antiviral Res. 2022. PMID: 35358601 Free article.
Molecular Epidemiology of Respiratory Syncytial Virus during 2019-2022 and Surviving Genotypes after the COVID-19 Pandemic in Japan.
Yoshioka S, Phyu WW, Wagatsuma K, Nagai T, Sano Y, Taniguchi K, Nagata N, Tomimoto K, Sato I, Kaji H, Sugata K, Sugiura K, Saito N, Aoki S, Suzuki E, Shimada Y, Hamabata H, Chon I, Otoguro T, Watanabe H, Saito R. Yoshioka S, et al. Among authors: suzuki e. Viruses. 2023 Dec 4;15(12):2382. doi: 10.3390/v15122382. Viruses. 2023. PMID: 38140623 Free PMC article.
Humoral immune response to influenza A(H1N1)pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic.
Kumagai T, Nakayama T, Okuno Y, Kase T, Nishimura N, Ozaki T, Miyata A, Suzuki E, Okafuji T, Okafuji T, Ochiai H, Nagata N, Tsutsumi H, Okamatsu M, Sakoda Y, Kida H, Ihara T. Kumagai T, et al. Among authors: suzuki e. Viral Immunol. 2014 Oct;27(8):368-74. doi: 10.1089/vim.2014.0010. Epub 2014 Sep 11. Viral Immunol. 2014. PMID: 25211638
Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season.
Kamada M, Nagai T, Kumagai T, Igarashi M, Ihara T, Okafuji T, Ochiai H, Sakiyama H, Shimomura K, Suzuki E, Torigoe S, Miyazaki C, Miyata A, Yuri K, Ito Y, Nakayama T, Kase T, Okuno Y. Kamada M, et al. Among authors: suzuki e. Vaccine. 2006 Apr 24;24(17):3618-23. doi: 10.1016/j.vaccine.2006.01.067. Epub 2006 Feb 28. Vaccine. 2006. PMID: 16530300
Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes.
Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, Kumagai T, Sakiyama H, Miyata A, Ochiai H, Ihara T, Okafuji T, Okafuji T, Nagai T, Suzuki E, Shimomura K, Ito Y, Miyazaki C. Inou Y, et al. Among authors: suzuki e. J Med Virol. 2004 May;73(1):97-104. doi: 10.1002/jmv.20065. J Med Virol. 2004. PMID: 15042655
1,791 results